ANA BY CLIA ANTI NUCLEAR ANTIBODY SCREENING

The ANA by CLIA (Anti‑Nuclear Antibody screening using chemiluminescence immunoassay) is a sensitive blood test that detects antibodies targeting cellular nuclei; the sample is collected at home by a trained phlebotomist across Dubai and the UAE to ensure quality and convenience. It serves as an early screening tool for autoimmune connective tissue disorders such as systemic lupus erythematosus, Sjögren’s syndrome, scleroderma and mixed connective tissue disease, and is recommended for people with unexplained joint pain, rashes, photosensitivity or recurrent pregnancy loss. A routine venous blood draw is required (no special fasting), results are delivered via secure electronic report—typically within 24–72 hours depending on the laboratory—and any positive or borderline result should be reviewed by a clinician who may request confirmatory ENA testing and clinical correlation.

• Antinuclear Antibodies (ANA) — CLIA screening
• ANA quantitative titer
• Reflex pattern reporting (IFA/confirmatory, if indicated)

• Chemiluminescence immunoassay (CLIA) ANA screening for high-sensitivity antinuclear antibody detection
• Home blood draw by certified phlebotomists available across Dubai and the UAE
• Rapid laboratory processing with secure digital report ready for your UAE healthcare provider
• Useful as an initial screen for autoimmune connective tissue disorders such as SLE, Sjögren’s, and scleroderma
• Provides quantitative antibody results with interpretive notes; clinician follow-up recommended

• High-sensitivity chemiluminescent (CLIA) ANA screening for accurate detection of antinuclear antibodies
• Home venous blood collection by professional phlebotomists across Dubai and the UAE
• Rapid laboratory turnaround with clear electronic report including reference ranges and recommended next steps
• Useful for screening or monitoring autoimmune conditions (e.g., SLE, Sjögren’s, scleroderma) to support clinical evaluation
• Convenient booking, no fasting required, and easy billing in AED for UAE patients

• Chemiluminescent immunoassay (CLIA) method for sensitive and specific ANA screening
• Venous blood collection at home by licensed phlebotomists, available across Dubai and the UAE
• Fast laboratory turnaround with a quantitative report designed to support clinical diagnosis and referrals
• Ideal for early detection of systemic autoimmune conditions (e.g., SLE, Sjögren’s); follow-up with your physician recommended